The Wall Street Journal on Friday examined "unbranded product advertising" for brand-name drugs, which allow drugmakers to drive television viewers to Web sites promoting drugs without the requirement of listing the products' side effects in the TV advertisement. FDA rules state that if an advertisement does not name a drug directly, it does not need to include a listing of possible side effects. ...